肠道微生物群对肠道透性的影响 肝脏和肠道疾病
Punnag Saha1, Phillipp Hartmann1,2
1Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Microorganisms
|June 27, 2025
概括
肠道微生物组的变化与慢性肝脏和炎症性肠道疾病有关,影响肠道屏障的完整性. 针对微生物组为这些疾病提供了有希望的治疗策略.
科学领域:
- 胃肠道学和肝病学
- 微生物组研究 微生物组研究
- 免疫学 免疫学 免疫学
背景情况:
- 肝胆道和胃肠道疾病导致全球显著的发病率和死亡率.
- 这些疾病的共同点是肠道微生物组失调和肠道透性增加.
- 有害的微生物产品有助于疾病病理生理学.
研究的目的:
- 审查各种慢性疾病中肠道微生物组的变化.
- 阐明微生物组在肠道屏障破坏和疾病进展中的作用.
- 讨论针对微生物的治疗干预措施和精准医学.
主要方法:
- 关于肠道微生物组和肝胆/胃肠道疾病的研究文献综述.
- 分析将微生物组变化与肠道屏障功能联系起来的机制.
- 综合有关治疗策略的数据,包括益生菌,益生菌和便微生物群移植.
主要成果:
- 在各种慢性肝脏和炎症性肠道疾病中观察到肠道微生物组成的显著变化.
- 微生物组失调直接导致肠道透性和炎症的增加.
- 针对肠道微生物组的治疗干预已在临床前和临床环境中证明有效.
结论:
- 肠道微生物组失调是慢性肝胆道和胃肠道疾病的发病的一个关键因素.
- 调节肠道微生物组代表了管理这些疾病的可行治疗途径.
- 精准医学方法为基于微生物组的治疗提供了个性化策略.
相关概念视频
Factors Influencing Drug Absorption: Disease States and Pharmacology
830
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
830
Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342
Hepatic Drug Clearance: Role of Transporters
109
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
109
Irritable Bowel Syndrome I: Introduction
399
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
399
Physiology of Enteric Nervous System and Gut Health
433
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
433
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
269
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
269


